Literature DB >> 9037604

Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23.

P J Byrd, T Stankovic, C M McConville, A D Smith, P R Cooper, A M Taylor.   

Abstract

We have localized the human homolog of the rabbit vasopressin-activated calcium-mobilizing receptor VACM-1 to a region close to the gene for ataxia telangiectasia ATM on chromosome 11q22-23. We have determined the complete amino acid sequence of the human Hs-VACM-1 protein, which is 780 amino acids long. The human and rabbit sequences are highly conserved, differing at only seven amino acids. Northern analysis of the human gene showed expression in a wide range of human tissues. The Hs-VACM-1 gene has homology with the Caenorhabditis elegans gene Ce-cul-5, a member of a family of cullin genes that are involved in cell cycle regulation and that might, when mutated, contribute to tumor progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037604     DOI: 10.1101/gr.7.1.71

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  17 in total

1.  Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.

Authors:  E Querido; P Blanchette; Q Yan; T Kamura; M Morrison; D Boivin; W G Kaelin; R C Conaway; J W Conaway; P E Branton
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

2.  Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter.

Authors:  W W Noll; D R Belloni; J L Rutter; C A Storm; A R Schned; L Titus-Ernstoff; M S Ernstoff; C E Brinckerhoff
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Submicroscopic interstitial deletion of chromosome 11q22.3 in a girl with mild mental retardation and facial dysmorphism: Case report.

Authors:  Danijela Krgovic; Natasa Marcun Varda; Andreja Zagorac; Nadja Kokalj-Vokac
Journal:  Mol Cytogenet       Date:  2011-08-22       Impact factor: 2.009

4.  CUL-4A is critical for early embryonic development.

Authors:  Binghui Li; Joseph C Ruiz; Kristin T Chun
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 5.  The functions and properties of cullin-5, a potential therapeutic target for cancers.

Authors:  Feng Gao; Yimin Fan; Bolun Zhou; Weihua Guo; Xingjun Jiang; Jing Shi; Caiping Ren
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

6.  Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5.

Authors:  Shaneen S Baxter; Lauren A Carlson; Alejandro M S Mayer; Mary L Hall; Michael J Fay
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-01-01       Impact factor: 2.416

7.  Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery.

Authors:  Josephine N Harada; Anna Shevchenko; Andrej Shevchenko; David C Pallas; Arnold J Berk
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Phosphorylation of VACM-1/Cul5 by protein kinase A regulates its neddylation and antiproliferative effect.

Authors:  Shirley E Bradley; Alyssa E Johnson; Isabelle P Le; Elizabeth Oosterhouse; Michael P Hledin; Gabriel A Marquez; Maria Burnatowska-Hledin
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

9.  E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells.

Authors:  Rahul S Samant; Paul A Clarke; Paul Workman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-23       Impact factor: 11.205

10.  Estrogen-dependent growth and estrogen receptor (ER)-alpha concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene.

Authors:  Alyssa E Johnson; Isabelle P Le; Abby Buchwalter; Maria A Burnatowska-Hledin
Journal:  Mol Cell Biochem       Date:  2006-12-22       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.